Search
Descriptor English: Malignant Carcinoid Syndrome
Descriptor Spanish: Síndrome Carcinoide Maligno
Descriptor síndrome carcinoide maligno
Scope note: Complejo sintomático que acompaña a los TUMORES CARCINOIDES y se caracteriza por crisis de rubefacción intensa de la piel, diarrea acuosa, broncoconstricción, caídas repentinas de la tensión arterial, edema y ascitis. Los tumores carcinoides generalmente se sitúan en el tubo digestivo y metastatizan en el hígado. Los síntomas se deben a la secreción tumoral de serotonina, prostaglandinas y otras sustancias biológicamente activas. Las manifestaciones cardíacas constituyen la CARDIOPATÍA CARCINOIDE. (Dorland, 27th ed; Stedman, 25th ed)
Descriptor Portuguese: Síndrome do Carcinoide Maligno
Descriptor French: Syndrome carcinoïde malin
Entry term(s): Carcinoid Syndrome, Malignant
Carcinoid Syndromes, Malignant
Malignant Carcinoid Syndromes
Syndrome, Malignant Carcinoid
Syndromes, Malignant Carcinoid
Tree number(s): C04.557.465.625.650.200.500
C04.557.470.200.025.200.500
C04.557.580.625.650.200.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008303
Scope note: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)
Annotation: for cardiac manifestation index CARCINOID HEART DISEASE
Allowable Qualifiers: BL blood
CF cerebrospinal fluid
CI chemically induced
CL classification
CN congenital
CO complications
DG diagnostic imaging
DH diet therapy
DI diagnosis
DT drug therapy
EC economics
EH ethnology
EM embryology
EN enzymology
EP epidemiology
ET etiology
GE genetics
HI history
IM immunology
ME metabolism
MI microbiology
MO mortality
NU nursing
PA pathology
PC prevention & control
PP physiopathology
PS parasitology
PX psychology
RH rehabilitation
RT radiotherapy
SU surgery
TH therapy
UR urine
VE veterinary
VI virology
DeCS ID: 8476
Unique ID: D008303
NLM Classification: WI 435
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2018/06/29
Malignant Carcinoid Syndrome - Preferred
Concept UI M0012930
Scope note A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)
Preferred term Malignant Carcinoid Syndrome
Entry term(s) Carcinoid Syndrome, Malignant
Carcinoid Syndromes, Malignant
Malignant Carcinoid Syndromes
Syndrome, Malignant Carcinoid
Syndromes, Malignant Carcinoid



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey